Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value
$1.46B
Total Bought
$530.64M
Total Sold
$123.34M
Net Transaction
+$407.30M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
INSMED INC(INSM)12,960,53815,397,975+2,437,437894,7961,200,88882.08%+306,093
VERONA PHARMA PLC810,4493,923,204+3,112,75537,637245,98516.81%+208,348
ALLOGENE THERAPEUTICS INC010,449,791+10,449,791016,1971.11%+16,197
NURIX THERAPEUTICS INC(NRIX)163,6810-163,6813,0840—-3,084
KEROS THERAPEUTICS INC(KROS)1,687,1350-1,687,13526,7070—-26,707
GERON CORP(GERN)9,569,8350-9,569,83533,8770—-33,877
JAZZ PHARMACEUTICALS PLC(JAZZ)484,5150-484,51559,6680—-59,668
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q1 2025 | TickerTrail